In stimulated cells, the mitogen-activated protein kinase ERK2 (extracellular signal-regulated kinase 2) concentrates in the nucleus. Evidence exists for CRM1-dependent, mitogen-activated protein kinase kinase-mediated nuclear export of ERK2, but its mechanism of nuclear entry is not understood. To determine requirements for nuclear transport, we tagged ERK2 with green fluorescent protein (GFP) and examined its nuclear uptake by using an in vitro import assay. GFP-ERK2 entered the nucleus in a saturable, time-and temperature-dependent manner. Entry of GFP-ERK2, like that of ERK2, required neither energy nor transport factors and was visible within minutes. The nuclear uptake of GFP-ERK2 was inhibited by wheat germ agglutinin, which blocks nuclear entry by binding to carbohydrate moieties on nuclear pore complex proteins. The nuclear uptake of GFP-ERK2 also was reduced by excess amounts of recombinant transport factors. These findings suggest that ERK2 competes with transport factors for binding to nucleoporins, which mediate the entry and exit of transport factors. In support of this hypothesis, we showed that ERK2 binds directly to a purified nucleoporin. Our data suggest that GFP-ERK2 enters the nucleus by a saturable, facilitated mechanism, distinct from a carrier-and energy-dependent import mechanism and involves a direct interaction with nuclear pore complex proteins.mitogen-activated protein kinase ͉ import ͉ FXFG motif ͉ nucleoporins M itogen-activated protein (MAP) kinases are ubiquitous protein kinases that integrate cell surface signals by phosphorylating proteins throughout the cell. The MAP kinase ERK2 (extracellular signal-regulated kinase 2) targets proteins in multiple cell compartments after an activating stimulus. Stimuli induce the nuclear accumulation of ERK2 from its resting location in the cytoplasm of many types of cells, including fibroblasts, epithelial cells, and neuroendocrine cells (1, 2).The location of ERK2 is a significant factor in determining its ability to phosphorylate key substrates and thereby influence cell behavior. Controlling the localization of ERK2 is a mechanism by which cell function may be influenced. For example, PEA15, which promotes the cytoplasmic retention of ERK2, is overexpressed in disease states, such as type II diabetes and breast cancer (3, 4). ERK2 is active and constitutively nuclear in certain breast cancer cells, but excluded from the nucleus in certain nonsmall cell lung cancers (ref. 5, S. Muneer, personal communication). In addition to extensive data suggesting a correlation between phenotypes and ERK2 localization, some cell behaviors have been demonstrated to occur only if ERK2 accumulates in the nucleus. For example, the nuclear localization of ERK2 is essential for morphological transformation of 3T3 fibroblasts and neurite extension in PC12 cells (6, 7). An understanding of how ERK2 localization is regulated will provide important insights into its normal function and disease mechanisms.ERK2 subcellular localization is mediated by interactions w...